Eric Hanesana

Eric Hanesana, M.S., ASQ-CPGP, currently serves as the Senior Director of Quality Assurance at Aspen Neuroscience, Inc., where the focus is on developing innovative autologous cell therapies for neurological diseases. Previously, Eric held leadership positions in quality assurance and control at notable companies such as Thermo Fisher Scientific, Sorrento Therapeutics, PaxVax, Stemedica Cell Technologies, and Intertek Pharmaceutical Services, demonstrating expertise in the biopharmaceutical sector. Educational qualifications include a Master of Science in Biotechnology Regulatory Affairs from the University of Maryland Global Campus and a Bachelor of Science in Human Biology from UC San Diego. Eric Hanesana is recognized for proficiency in method development and validation, particularly for challenging immunoassays.